GLP‐1 analogues inhibitors vs sulphonylureas
Adverse events other than hypoglycaemia
It is very uncertain whether GLP‐1 analogues inhibitors changes adverse events other than hypoglycaemia compared with sulphonylureas (very low certainty).
1 finding from 1 review
- Interventions for people with type 2 diabetes mellitus fasting during Ramadan 2023 · Cochrane Headline outcomes onlyRR 1.5 [0.86, 2.61]3 studies · 499 participantsVery low